Viewing Study NCT00660751


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2025-12-25 @ 9:51 PM
Study NCT ID: NCT00660751
Status: COMPLETED
Last Update Posted: 2017-10-11
First Post: 2008-04-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
Sponsor: Rambam Health Care Campus
Organization:

Study Overview

Official Title: The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The role of central serotonergic and adrenergic systems in the effectiveness of DNIC (Diffuse Noxious Inhibitory Control) will be tested before and after taking Duloxetine and Placebo in a double blind study.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: